Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 116

Results For "Inc"

5399 News Found

Takeda appoints Annapurna Das as the General Manager, India Operations
People | May 17, 2024

Takeda appoints Annapurna Das as the General Manager, India Operations

Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines


Biocon posts Q4 FY24 PAT at Rs. 135 Cr
News | May 17, 2024

Biocon posts Q4 FY24 PAT at Rs. 135 Cr

EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%


Cresset opens new new India HQ in Bengaluru to tap potential of APAC market
News | May 17, 2024

Cresset opens new new India HQ in Bengaluru to tap potential of APAC market

Cresset’s new India site will support the growing demands of Cresset’s APAC customer base


Cipla invests additional Rs. 26 crore in Achira
News | May 16, 2024

Cipla invests additional Rs. 26 crore in Achira

Achira is engaged in development and commercialization of PoC medical test kits in India


Granules India posts Q4 FY24 consolidated PAT at Rs. 129.64 Cr
News | May 16, 2024

Granules India posts Q4 FY24 consolidated PAT at Rs. 129.64 Cr

The company has posted net profit of Rs. 405.31 crores for the Financial Year ended March 31, 2024


Ind-Swift posts Q4 FY24 consolidated PAT at Rs. 37.53 Cr
News | May 16, 2024

Ind-Swift posts Q4 FY24 consolidated PAT at Rs. 37.53 Cr

The company has posted net profit of Rs. 14.23 crores for the Financial Year ended March 31, 2024


Bayer starts Phase I study with novel targeted radionuclide therapy in advanced metastatic prostate cancer
Diagnostic Center | May 16, 2024

Bayer starts Phase I study with novel targeted radionuclide therapy in advanced metastatic prostate cancer

225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer


IOL Chemicals and Pharmaceuticals posts Q4 FY24 consolidated PAT at Rs. 27.62 Cr
News | May 15, 2024

IOL Chemicals and Pharmaceuticals posts Q4 FY24 consolidated PAT at Rs. 27.62 Cr

The company has posted net profit of Rs.134.43 crores for the Financial Year ended March 31, 2024


Thyrocare Technologies posts Q4 FY24 consolidated PAT at Rs. 17.78 Cr
News | May 15, 2024

Thyrocare Technologies posts Q4 FY24 consolidated PAT at Rs. 17.78 Cr

The company has posted net profit of Rs.70.76 crores for the Financial Year ended March 31, 2024


Gujarat Themis Biosyn posts Q4 FY24 PAT at Rs. 15.88 Cr
News | May 15, 2024

Gujarat Themis Biosyn posts Q4 FY24 PAT at Rs. 15.88 Cr

The company has posted net profit of Rs. 59.16 crores for the Financial Year ended March 31, 2024